Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Value of AD Biomarkers in Elderly New-onset Epilepsy
NCT02861846Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2017
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Number of patients with CSF biomarkers suggestive of Alzheimer's Disease at 2 years. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT02861846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02861846.